Will patents hinder the progress made in HIV treatment?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1503, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kidney disease a barrier to HIV treatment?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Enfuvirtide: a new revolu-T20n in HIV treatment?

Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Is it worth increasing dose-density in cancer treatment?

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

CXCR2: a target for pancreatic cancer treatment?

By Hertzer Kathleen M Donald Graham W Hines O Joe

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 667-680

Informa Healthcare

Access to resources Recommend Favorite

Halofuginone for liver fibrosis prevention and treatment?

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite